Marc Zuckermann

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Developmental determinants of male bias in medulloblastoma.

Developmental determinants of male bias in medulloblastoma.

Journal: bioRxiv : the preprint server for biology
Published: April 03, 2026

A Cre-mediated copy number variant compromises the reliability of a LoxP-STOP-LoxP-PLAG1 driven brain tumor model.

A Cre-mediated copy number variant compromises the reliability of a LoxP-STOP-LoxP-PLAG1 driven brain tumor model.

Journal: Neuro-oncology advances
Published: September 03, 2025

Functionally distinct ALK and ROS1 fusions detected in infant-type hemispheric gliomas converge on STAT3 and SHP2 activation.

Functionally distinct ALK and ROS1 fusions detected in infant-type hemispheric gliomas converge on STAT3 and SHP2 activation.

Journal: Cell reports
Published: June 02, 2025

Investigation of a global mouse methylome atlas reveals subtype-specific copy number alterations in pediatric cancer models.

Investigation of a global mouse methylome atlas reveals subtype-specific copy number alterations in pediatric cancer models.

Journal: Nature genetics
Published: December 06, 2024

A simplified preparation method for single-nucleus RNA-sequencing using long-term frozen brain tumor tissues.

A simplified preparation method for single-nucleus RNA-sequencing using long-term frozen brain tumor tissues.

Journal: Scientific reports
Published: August 01, 2024

Loss of Elp1 in cerebellar granule cell progenitors models ataxia phenotype of Familial Dysautonomia.

Loss of Elp1 in cerebellar granule cell progenitors models ataxia phenotype of Familial Dysautonomia.

Journal: Neurobiology of disease
Published: April 18, 2024

Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy.

Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy.

Journal: Molecular cancer
Published: November 04, 2023

Mapping pediatric brain tumors to their origins in the developing cerebellum.

Mapping pediatric brain tumors to their origins in the developing cerebellum.

Journal: Neuro-oncology
Published: August 03, 2023

The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma models.

The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma models.

Journal: Neuro-oncology
Published: July 26, 2022

Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes.

Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes.

Journal: Cancer discovery
Published: September 04, 2019

YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis.

YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis.

Journal: Nature communications
Published: January 08, 2019

A novel cloning strategy for one-step assembly of multiplex CRISPR vectors.

A novel cloning strategy for one-step assembly of multiplex CRISPR vectors.

Journal: Scientific reports
Published: March 26, 2018
Showing 1-12 of 17

Last Updated: 09/26/2026